To assess whether we could detect ARS1620-derived epitopes in KRAS G12C tumor xenografts, we treated nude mice bearing xenografts of H358 cells with ARS1620 (200 mg/kg, once daily) and analyzed dissected tumor tissue after 24 h or 72 h. This evidence concerns the gene KRAS and neoplasm.